EFFECT OF 5-LIPOXYGENASE INHIBITOR, VIA-2291, ON EPICARDIAL FAT VOLUME IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME

被引：0
|
作者：
Almeida, Shone [1 ]
Budhoff, Matthew [1 ]
机构：
[1] Los Angeles Biomed Res Inst, Torrance, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32134-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1593
引用
收藏
页码：1593 / 1593
页数：1
相关论文
共 50 条
  • [1] Effect of 5-lipoxygenase inhibitor, VIA-2291 (Atreleuton), on epicardial fat volume in patients with recent acute coronary syndrome
    Almeida, Shone O.
    Ram, Reuben J.
    Kinninger, April
    Budoff, Matthew J.
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2020, 14 (04) : 343 - 348
  • [2] Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome
    Tardif, Jean-Claude
    L'Allier, Philippe L.
    Ibrahim, Reda
    Gregoire, Jean C.
    Nozza, Anna
    Cossette, Marieve
    Kouz, Simon
    Lavoie, Marc-Andre
    Paquin, Janie
    Brotz, Tilmann M.
    Taub, Rebecca
    Pressacco, Josephine
    CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (03) : 298 - 307
  • [3] 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) Treatment Decreases Epicardial and Pericardial Adipose Tissue in Patients with Recent Acute Coronary Syndrome
    Ram, Reuben J.
    Larijani, Vahid Nabavi
    Floares, Ferdinand R.
    Prabhu, Sachidanand
    Ram, Nina
    Raskett, Michael
    Ardestani, Armand
    Ahmadi, Naser
    Gregoire, Jean
    Pressacco, Josephine
    Budoff, Matthew
    Tardif, Jean-Claude
    CIRCULATION, 2012, 126 (21)
  • [4] 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) Intake Improves Left Ventricular Ejection Fraction in Patients with Recent Acute Coronary Syndrome
    Ram, Reuben J.
    Larijani, Vahid Nabavi
    Prabhu, Sachidanand
    Dialing, Christopher
    Ardestani, Armand
    Ram, Nina
    Ahmadi, Naser
    Ibrahim, Reda
    Pressacco, Josephine
    Tardif, Jean-Claude
    Budoff, Matthew J.
    CIRCULATION, 2012, 126 (21)
  • [5] Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study
    Matsumoto, Suguru
    Ibrahim, Reda
    Gregoire, Jean C.
    L'Allier, Philippe L.
    Pressacco, Josephine
    Tardif, Jean-Claude
    Budoff, Matthew J.
    CLINICAL CARDIOLOGY, 2017, 40 (04) : 210 - 215
  • [6] 5-lipoxygenase Inhibitor Via-2291 (atreleuton) Reduces Inflammation and Coronary Necrotic Core Plaque and Improves Left Ventricular Function in Patients After an Acute Coronary Syndrome
    Ahmadi, Naser
    Nabavi, Vahid
    Ram, Reuben J.
    Flores, Ferdinand
    Baskett, Michael
    L'Allier, Philippe L.
    Pressacco, Josephine
    Tardif, Jean-Claude
    Budoff, Matthew
    CIRCULATION, 2012, 126 (21)
  • [7] Effect of Treatment with 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) on Coronary Plaque Progression: A serial CT Angiography Study
    Budoff, Matthew J.
    Ram, Reuben
    Larinjani, Vahid
    Prabhu, Sachidanand
    Dailing, Christopher
    Ram, Nina
    Ardestani, Armand
    Ahmadi, Naser
    Ibrahim, Reda
    Gregoire, Jean
    L'Allier, Phillipe L.
    Pressacco, Josephine
    Tardif, Jean-Claude
    CIRCULATION, 2012, 126 (21)
  • [8] Evaluation of Coronary Artery Atherosclerotic Plaque by Serial 64-Slice Multidetector Computed Tomography in Patients with Recent Acute Coronary Syndrome Treated for 6 Months with 5-Lipoxygenase Inhibitor VIA-2291
    Pressacco, Josephine
    Taub, Rebecca
    Cossette, Marieve
    Nozza, Anna
    Paquin, Janie
    Kouz, Simon
    Ibrahim, Reda
    Gregoire, Jean
    L'Allier, Philippe
    Chiang, Ed
    Brotz, Tilmann M.
    Fortier, Louise
    Tardif, Jean-Claude
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E112 - E112
  • [9] A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome
    Gaztanaga, Juan
    Farkouh, Michael
    Rudd, James H. F.
    Brotz, Tilmann M.
    Rosenbaum, David
    Mani, Venkatesh
    Kerwin, Todd C.
    Taub, Rebecca
    Tardif, Jean-Claude
    Tawakol, Ahmed
    Fayad, Zahi A.
    ATHEROSCLEROSIS, 2015, 240 (01) : 53 - 60
  • [10] Attenuation of atherosclerosis and monocyte-macrophage inflammation in ApoE-Deficient mice treated with the 5-lipoxygenase inhibitor VIA-2291
    Hansson, Anna
    Tabibiazar, Raymond
    Wohlgemuth, Jay G.
    Sanan, David A.
    Quertermous, Thomas
    CIRCULATION, 2007, 116 (16) : 209 - 209
12345